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Abstract
Objective Vasoconstrictor capacity, skeletal muscle tone,
and renal sodium retention are involved in the pathogenesis
of fainting. As muscle contractility and ion transport are
highly energy-demanding processes, we hypothesized that
a low activity of the energy-generating enzyme creatine
kinase (CK) is associated with a higher risk of fainting. The
aim of this observational study was to explore the associ-
ation of vasovagal syncope with low CK.
Methods A random sample of 1,000 subjects aged
34–60 years was drawn from the general population, with
442 subjects eventually included in the study. Data on
fainting history were collected with the investigators blin-
ded to participants’ CK level. We prepared this report
according to the ‘‘Strengthening the Reporting of Obser-
vational Studies in Epidemiology’’ (STROBE) statement.
The main outcome was the lifetime cumulative incidence
of vasovagal syncope in subjects with low versus high-
normal serum CK after a 3 days rest.
Results The proportion of fainters within the high CK
group was 29 out of 130 (22%) versus 121 out of 312
(39%) in the low CK group; a 73% greater occurrence of
fainting with low CK (P = 0.0005). This ﬁnding was
consistent across recurrent fainters, and in men and
women.
Interpretation Low CK is associated with a 73% higher
incidence of fainting in a random population sample. The
association is biologically plausible, as CK enhances car-
diovascular and skeletal muscle contractility and salt
retention. The presented data suggest that low CK activity
is a potential new risk factor for vasovagal syncope.
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Introduction
We proposed that creatine kinase (CK), the central regu-
latory enzyme of energy metabolism, may increase ortho-
static tolerance. The enzyme catalyzes the reversible
transfer of the high-energy phosphate moiety (P) between
creatine and ADP:
MgADP þ PCreatine þ Hþ $ MgATP þ Creatine;
with a capacity to regenerate ATP at a higher rate than
glycolysis and oxidative phosphorylation together [4, 5, 8,





In addition, the enzyme is active near myosin light chain
kinase and myosin ATPase, the principal enzymes involved
in muscle contraction [4, 5, 8, 10, 27, 29]. CK thus fuels the
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renal sodium retention, and of cardiovascular and skeletal
muscle contractility [2, 4, 5, 8, 10, 14, 17, 27, 29].
Vasovagal syncope refers to a sudden loss of con-
sciousness with a loss of postural tone, due to a rapid fall in
blood pressure and cerebral perfusion, resulting from reﬂex
vasodilation and bradycardia. The condition, which can
be debilitating when it occurs recurrently, is provoked
by diverse stimuli including strong emotion, Valsalva
maneuvers, and prolonged standing [9, 11, 12, 15, 18, 24].
A diminished vasoconstrictor capacity, reduced circulating
blood volume, and decreased skeletal muscle tone have
been identiﬁed as causal factors, but it remains unclear why
some people faint more frequently than others [9, 11, 12,
15, 18, 24].
We hypothesized that subjects with a low CK activity
have a lower cellular energetic capacity to withstand
orthostatic and other stresses that lead to fainting. In this
observational study, we assessed in a random population
sample, whether the cumulative incidence of vasovagal
syncope is higher with low CK.
Methods
In preparing this report, we followed the STROBE (The
Strengthening the Reporting of Observational Studies in
Epidemiology) Statement, a guideline intended to protocol
and improve the reporting of observational studies [28].
Study population
We analyzed a random sample of the white population
participating in the Cardiovascular Risk proﬁle of native
Dutch people in the Netherlands (CRANS) study, a sister
study to the ‘‘SUrinamese in the Netherlands: Study on
EThnicity and health’’ (SUNSET) Study [5], cross-
sectional surveys on cardiovascular risk factors of people
living in Amsterdam, the Netherlands, conducted from
2001 to 2003. The institutional review committee approved
the study and the participants gave written informed
consent.
The methods have been previously reported [5, 6]. In
brief, registration ofﬁces of the selected municipalities in
Amsterdam provided the CRANS study group a stratiﬁed
random population sample of 1,000 non-institutionalized
white persons aged 34–60 years. The overall response rate
was 57%. All prospective participants were invited for an
oral interview. The respondents were interviewed at home
by trained study-personnel. The questionnaire included
demographic data, cardiovascular health status, and risk
factors including life style, diet and smoking, and history of
syncope.
Incidence of syncope
During a visit at home, data were collected on the self-
reported occurrence of vasovagal syncope, as deﬁned by
the European Society of Cardiology [9]. This structured
interview included the occurrence of loss of conscious-
ness, and if applicable, the frequency of these episodes,
the age at the ﬁrst episode, subsequent occurrences if any,
and the perceived trigger of the episodes, as previously
described [9, 13, 20, 21]. Participants were speciﬁcally
questioned regarding the presence of diagnosed seizure
disorders, diagnosed cardiac disease, and other possible
causes of a loss of consciousness, as recommended [9, 13,
20, 21].
Physical examination
All participants were invited to the hospital for a physical
examination. We instructed participants to abstain from
heavy exercise during 3 days before visiting our hospital.
Walking, driving, and normal daily activities were allowed.
Physical examination included height, weight, and blood
pressure levels. Blood pressure was measured in the
morning in all participants, in a quiet room in the sitting
position, with an Omron M4 oscillometric device (Omron
Healthcare Europe B.V., Hoofddorp, The Netherlands). An
appropriately adjusted cuff size was used on the non-
dominant arm, which was supported at heart level. To
account for blood pressure variability, we used the mean of
the ﬁrst two consecutive readings with a maximum of
5 mmHg difference [5].
Serum CK estimations
Laboratory studies included serum CK activity after 3 days
of rest, as a measure of tissue CK activity as previously
described [5]. In otherwise healthy people, the release of
the enzyme from tissue at rest is proportional to the level of
tissue CK activity [5]. CK activity was estimated with
automated analyzers (Roche/Hitachi Systems, Roche
Diagnostics, Indianapolis, IN, USA), according to the
procedure recommended by the International Federation of
Clinical Chemistry [25].
Exclusion criteria
Exclusion criteria for our analyses included seizure disor-
ders and syncope with an established cause, such as
intoxication or cardiac disease [9, 13]. We also excluded
participants with treated hypertension, as postural hypo-
tension might be a side effect of antihypertensive medi-
cation [9].
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Outcome
The primary outcome was the difference in lifetime
cumulative incidence of vasovagal syncope between sub-
jects with low versus high CK activity. We opted to
dichotomize the data (low vs. high CK) around the popu-
lation median for serum CK activity for non-black people
(\111 IU/l vs. C111 IU/l), as previously reported by our
group [6]. We performed a sensitivity analysis and recal-
culated the primary outcome post hoc using tertiles for CK
based on population data, with similar results (data not
shown).
As a secondary outcome, we analyzed the primary
outcome in participants with and without recurrent faint-
ing; and in men and women. The tertiary outcome was the
ﬁrst-order partial correlation between a history of fainting,
and signiﬁcant correlates of this outcome, controlling for
log CK activity as a continuous measure.
Sample size calculation
Based on differences in syncope incidence between ethnic
subgroups known to differ in serum CK activity [6, 20, 21],
and the expected greater proportion of white subjects in the
predeﬁned low CK group [5, 6], we estimated to ﬁnd a 50%
higher syncope rate with low-normal CK, and calculated
we needed 209 subjects in the low CK group and 105 in the
high CK group to detect this difference with two-tailed
a = 0.05 and 1 - b = 0.80.
Analyses
Lifetime cumulative incidence was calculated as the pro-
portion of individuals who had at least one episode of
vasovagal syncope during their life [9, 13]. Because of the
skewed distribution of CK, we performed a log transfor-
mation to the base of ten on the CK data, and excluded data
above the 97.5 percentile [5, 6]. Differences in study
parameters between the low and high CK group were
calculated with Fisher’s exact test for fainting and sex, and
with the unpaired t test for the continuous measures age,
systolic blood pressure (SBP), body mass index (BMI), and
CK, before calculating the proportional difference in the
cumulative rate of fainting with low versus high-normal
CK activity as the primary outcome. Conﬁdence intervals
for the proportions were estimated with the adjusted Wald
method.
As CK is proposed to be an intervening variable that
mediates the effect of sex and obesity on cardiovascular
function [7], and a causal factor affecting blood pressure
[5], we assessed to which extent the continuous measure
log CK explained the effect of these parameters on fainting
history with partial correlation analysis, which is com-
monly used in ‘‘causal’’ modeling of small models with
three to ﬁve variables [7]. Because we collected data on the
history of fainting in subjects aged 34–60 years, we did not
include the variable ‘‘current age’’ into the correlation
analyses.
Data in square brackets are 95% conﬁdence intervals,
unless otherwise speciﬁed. Where applicable, we consid-
ered a one-sided P value of\0.05 to be signiﬁcant, under
the assumption that subjects with high CK activity would
have a lower occurrence of fainting. Main statistical anal-
yses were performed with SPSS statistical software pack-
age for Windows, version 14.0 (SPSS Inc., Chicago, IL,
USA) and the Web-based computation facilities at http://
faculty.vassar.edu/lowry/VassarStats.html.
Results
We included 442 subjects (220 men) in the study. Partic-
ipants’ ﬂow is depicted in Fig. 1. Table 1 shows the sum-
mary data of the subjects with high versus low CK (as
deﬁned in Sect. ‘‘Methods’’) [6].
A total of 150 participants (34%) ever fainted during
their lifetime. The proportion of fainters within the high
Fig. 1 Participants’ ﬂow
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(39%) within the low CK group, an increase in fainters of
73% with low CK activity [OR 2.20 (95% CI 1.38–3.54),
P = 0.0005].
Furthermore, 96 subjects were recurrent fainters (2
fainting episodes or more, median 4 episodes), respec-
tively, 15 out of 130 (12%) in the high CK group, versus 81
out of 312 (26%) with low CK, an increase in recurrent
fainters of 117% with low CK [OR 2.67 (95% CI 1.48–
4.88), P = 0.0004].
In line with this, the proportion of high CK subjects
decreased in subgroups with increasing fainting frequency,
respectively, 35, 26, and 15%, for never, one-time, and
multiple fainters (one-way ANOVA, P\0.001; Fig. 2).
It is known that women tend to have a lower mean CK
activity than men [4, 6]. Women are also known to have a
greater tendency to faint [13, 20, 21]. Therefore, we reas-
sessed the results separately for subgroups of women and
men. The cut-off point in women for high versus low
occurrence of fainting was observed around a CK of
107 IU/l, with a drop in the percentage of fainters from
44% (88/199) below this cut-off point, to 11% (4/35)
fainters with a CK activity C107 IU/l, an OR of 6.14 (95%
CI 2.09–18.06) for fainting with low CK. For men, the cut-
off point was higher, at 130 IU/l, with a percentage of
fainters of 45% (74/164) below this cut-off point, versus
18% (13/72) fainters with a CK activity C130 IU/l, an OR
of 4.49 (95% CI 2.36–8.53) (P\0.001 for differences in
both groups).
Finally, as CK is proposed to be an intervening variable
between sex and BMI versus the outcome fainting, and a
causal factor affecting blood pressure [5, 7], we controlled
for CK as a continuous measure in ﬁrst-order partial cor-
relation analysis [7]. When controlling for CK, the small
but signiﬁcant negative correlations between a history of
fainting and male sex, SBP, and BMI (squared correlation
coefﬁcients, respectively, 1.23, 1.77, and 1.17; P\0.001),
showed a 55% reduction for sex, a 20% reduction for blood
pressure, and a 13% reduction for BMI, whereas the cor-
relation of fainting with sex was rendered insigniﬁcant.
Discussion
In this observational study, we explored in a random
population sample the association between CK and faint-
ing, and provide data indicating that men and women with
low CK faint more often than with high CK. In addition,
those with low CK experience their ﬁrst fainting episode at
a younger age. Moreover, the correlation analysis used
because CK is proposed to be a causal factor [7], indicated
that controlling for CK reduces the effect of blood pressure
and BMI on fainting, and renders the correlation of fainting
with sex insigniﬁcant.
Our observational data are in line with the observation
that subgroups of the population with high tissue and serum
CK, including men, obese people and black people, display
greater orthostatic tolerance [2–6, 9, 13, 16, 20–23, 25, 26].
However, our data cannot be considered proof of a causal
role for CK, although the evidence from previous studies
shows that CK has a central role in muscular contractility.
Table 1 Study parameters with
high and low CK
SBP systolic blood pressure,
BMI body mass index; CK
creatine kinase activity
*P\0.05 for differences in
mean values between low and
high CK groups
Study parameters High CK Low CK Total
N (men) 130 (104) 312 (116) 442 (220)
Age, years (SE) 47.9 (0.6) 47.4 (0.4) 47.6 (0.3)
SBP, mmHg (SE)* 128.1 (1.7) 120.9 (1.1) 123.0 (0.9)
BMI, kg/m
2(SE) 26.4 (0.4) 25.7 (0.3) 25.9 (0.2)
CK, IU/L (SE)* 161.5 (4.1) 72.1 (1.2) 98.4 (2.4)
History of fainting (N)* 29 121 150
Recurrent fainting (N)* 15 81 96
Age at ﬁrst fainting episode, years (SE)* 24 (2.3) 19 (1.0) 21 (0.9)






























Fig. 2 Fainting episode frequency and resting serum CK. The ﬁgure
shows a decreasing proportion of high CK subjects in categories of
increasing fainting episodes, respectively, 35, 26, and 15%, for never,
one-time, and multiple fainters (one-way ANOVA, P\0.001). The
numbers depicted in the circular chart denote the number of subjects
in each group
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principal method by which blood pressure is maintained
during orthostatic stress [12, 15, 24]. Therefore, the ability
to tolerate orthostatic stress is directly related to the ability
to increase vascular resistance, coined ‘‘vasoconstrictive
reserve’’ [12, 15, 24]. We showed that vascular contrac-
tility is CK-dependent in humans [8]. Therefore, high tis-
sue CK may augment cellular energetic capacity to
withstand gravitational and other stresses that provoke
syncope [9, 11, 12, 15, 18, 24], through enhancing vascular
tone and vasoconstrictor reserve [4, 5, 8]. Subjects with
high CK might thus have greater energy reserve to rapidly
respond to threatening hypotension, mainly through a
greater ability to suddenly increase peripheral vascular
resistance, resulting in a better protection of cerebral per-
fusion pressure. Furthermore, relatively high skeletal
muscle CK activity is associated with a predominance of
fast type 2 ﬁbers and anaerobic muscle metabolism
capacity, with capillary rarefaction reducing the peripheral
capacitance of vessels [19]. High muscle CK thus helps to
generate swift skeletal muscle responses, with less pooling
of blood, and greater vascular peripheral resistance.
Finally, CK is thought to fuel sodium retention in the
kidney, with a high CK leading to greater salt retaining
capacity [14, 17]. Therefore, low CK might decrease
orthostatic tolerance.
This observational study has some clinical and meth-
odological limitations. The diagnosis of vasovagal syncope
in this population study was based on history taking and
general physical examination. Although we excluded
patients with diagnosed cardiac or neurological diseases,
we might have missed syncope secondary to undiagnosed
cardiac and other disorders. However, subjects typically
had an incidence peak of syncope around the age of
20 years [13]. Compared to the 35% incidence of syncope
in our participants, the prevalence of epileptic seizures in a
similar young age group is much lower (less than 1%) and
syncope resulting from cardiac arrhythmias or structural
heart disease, i.e., cardiac syncope, is even less common
[9], and more importantly, not likely to systematically
differ between low and high CK groups, or to impact our
outcome. Furthermore, our study has a semi-cross-sectional
design in which current CK is compared to a history of
prior fainting, which may be subject to recall bias, although
this also should not systematically differ between high and
low CK groups. However, the design does create limita-
tions regarding the interpretation of the data. This study
should be considered to be hypothesis-generating [28],
providing initial data that suggest that low CK activity is a
risk factor for fainting.
Vasovagal syncope is well known in medical history
and in the public perception [1]. Because of its common
occurrence [9, 11–13, 15, 18, 24], it was suggested that
fainting is not a disease [1]. We proposed a new causal
factor that is both common and normal, the condition of
relatively low CK activity [4–6, 8]. Our observational
study clearly indicates that in a random population sam-
ple, low CK activity is associated with a 73% greater
incidence of fainting. The ﬁnding was apparent in both
men and women. In addition, we found evidence of a
greater occurrence of recurrent fainting with low CK, and
the ﬁrst fainting episode occurred at a younger age. The
observational design of the study does not permit causal
inferences, but as CK controls muscle contractility and
renal salt retention, our data may help understand the
greater occurrence of fainting in subgroups with low CK,
such as in women [9, 13]. Further studies are needed to
explore the potential role of tissue energy metabolism and
a low tissue energy reserve as a new risk factor for
vasovagal syncope.
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